[1]MITZNER SR, STANGE J, KLAMMT S, et al.Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS:results of a prospective, randomized, controlled clinical trial[J].Liver Transpl, 2000, 6 (3) :277-286.
|
[2]HEEMANN U, TREICHEL U, LOOCK J, et al.Albumin dialysis in cirrhosis with superimposed acute liver injury:a prospective, controlled study[J].Hepatology, 2002, 36 (4 Pt 1) :949-958.
|
[3] SEN S, DAVIES NA, MOOKERJEE RP, et al.Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure:a randomized controlled study[J].Liver Transpl, 2004, 10 (9) :1109-1119.
|
[4]HASSANEIN TI, TOFTENG F, BROWN RS, et al.Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis[J].Hepatology, 2007, 46 (6) :1853-1862.
|
[5]SALIBA F, CAMUS C, DURAND F, et al.Predictive factors of transplant free survival in patients with fulminant and sufbulminant hepatic failure:results from a randomized controlled multicenter trial[J].J Hepatol, 2009, 50:S89-90.
|
[6] BANARES R, NEVENS F, LARSEN FS, et al.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure:the RELIEF trial[J].Hepatology, 2013, 57 (3) :1153-1162.
|
[7]KOIVUSALO AM, KANTOLA T, AROLA J, et al.Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?[J].Ther Apher Dial, 2009, 13 (5) :413-418.
|
[8]GRODZICKI M, KOTULSKI M, LEONOWICZ D, et al.Results of treatment of acute liver failure patients with use of the prometheus FPSA system[J].Transplantation Proceedings, 2009, 41 (8) :3079-3081.
|
[9]SENTRK E, ESEN F, OZCAN PE, et al.The treatment of acute liver failure with fractionated plasma separation and adsorption system:Experience in 85 applications[J].J Clin Apher, 2010, 25 (4) :195-201.
|
[10]KRIBBEN A, GERKEN G, HAAG S, et al.Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure[J].Gastroenterology, 2012, 142 (4) :782-789.
|
[11]LARSEN FS, SCHMIDT LE, WENDON J, et al.Liver assisting with high-volume plasma exchange in patients with acute liver failure[J].Hepatology, 2010, 52 (Suppl S1) :376a.
|
[12]PARK CS, HWANG S, PARK HW, et al.Role of plasmapheresis as liver support for early graft dysfunction following adult living donor liver transplantation[J].Transplantation Proceedings, 2012, 44 (3) :749-751.
|
[13]NAKAE H, LGARASHI T, TAJIMI K, et al.Selective plasma exchange with dialysis in patients with acute liver failure[J].Ther Apher Dial, 2012, 16 (5) :467-471.
|
[14]NAKAE H, EGUCHI Y, YOSHIOKA T, et al.Plasma diafiltration therapy in patients with postoperative liver failure[J].Ther Apher Dial, 2011, 15 (4) :406-410.
|
[15]LIN W, KONG M, GAO YJ, et al.Control study on the immediate effect and adverse reaction of different types of artificial liver treatment of liver failure[J].J Clin Hepatol, 2011, 27 (3) :306-309. (in Chinese) 林伟, 孔明, 高玉娟, 等.不同类型人工肝治疗重型肝病的即刻疗效及不良反应对照[J].临床肝胆病杂志, 2011, 27 (3) :306-309.
|
[16]MEIJERS B, LALEMAN W, VERMEERSCH PA, et al.A prospective randomized open-label crossover trial of regional citrate anticoagulation vs.anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System[J].Crit Care, 2012, 16 (1) :R20.
|
[17] ZHANG Z, HONGYING N.Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy[J].Intensive Care Med, 2012, 38 (1) :20-28.
|